You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKesson
Harvard Business School
Boehringer Ingelheim
Baxter

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Milrinone Lactate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Milrinone Lactate In Dextrose 5% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, Hospira, West-ward Pharms Int, and Woodward. and is included in seven NDAs.

The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER is milrinone lactate. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

US ANDA Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5% In Plastic Container

A generic version of MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.

  Start Trial

Summary for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Children's Medical CenterPhase 3
Ottawa Heart Institute Research CorporationPhase 4
Cliniques universitaires Saint-Luc- Université Catholique de LouvainN/A

See all MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 076414-001 Aug 18, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075510-001 May 28, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075834-002 May 28, 2002 AP RX No Yes   Start Trial   Start Trial   Start Trial
West-ward Pharms Int MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 078113-001 May 21, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075834-001 May 28, 2002 AP RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Harvard Business School
Boehringer Ingelheim
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.